SEQ TECH
LIVE

Serial Number

90053652

Owner

Pro Bono Bio Entrepreneur Limited

Attorney

David M. Perry

Filing Date

Jul 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SEQ TECH Trademark

Serial Number: 90053652 • Registration: 6741996

SEQ TECH is a trademark filed by Pro Bono Bio Entrepreneur Limited on July 15, 2020. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Pro Bono Bio Entrepreneur Limited (10 trademarks)

4th floor,

Entity Type: 99

Trademark Details

Filing Date

July 15, 2020

Registration Date

May 31, 2022

Published for Opposition

January 18, 2022

Goods & Services

Pharmaceutical preparations and substances for treating pain and inflammation; veterinary and sanitary preparations and substances for treating pain and inflammation; chemical preparations for pharmaceutical purposes for treating pain and inflammation; diagnostic preparations and substances, all for medical and veterinary in vivo use; pharmaceuticals, namely, pharmaceutical preparations for treatment and diagnosis in the field of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; topical and parenteral preparations in the form of vesicles for treatment of pain, inflammation, osteoarthritis, and dermatological conditions; chemical preparations in the form of vesicles for medical and veterinary purposes for treating or diagnosing pain, inflammation, osteoarthritis, and dermatological conditions; chemical membranes and chemical aggregates being chemical reagents for medical and veterinary purposes; pharmaceutical preparations of arachidonic acids; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical and veterinary substances; cosmeceutical preparations for medical use, namely, pharmaceutical preparations for treating dermatological conditions; local anaesthetics; steroids; anti-inflammatory drugs; lipids for topical and parenteral use in treating dermatological conditions, namely, acne, psoriasis, eczema, rosacea, and photo- or age-damaged skin and collagen; pharmaceutical creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution for the treatment of pain or inflammation; surfactants for use in the treatment of or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, namely, inflammatory diseases and disorders that speed the onset of arthritic disorders and syndromes, inherited disease being haematological diseases, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; surfactants for use in the treatment of or prevention of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout and macular degeneration, AMD, fungal infection, and disorders related to fatty acid deficiencies; Veterinary therapeutic preparations and therapeutic pharmaceuticals in the fields of laminitis, debilitating joint diseases, bog spavin and bone spavin, bowed tendons, capped joints, curb (inflammation of the rear cannon bone below the point of hock), laminitis, navicular disease, osselets, ringbone, sesamoiditis, shoe boil, sidebone, speedy cut (striking of the inner lower side of the knee with the opposite limb), splints; veterinary therapeutic preparations and pharmaceuticals in the fields of sprains, stocking up, stringhalt, thoroughpin (swelling of the digital flexor tendon sheath), and windpuffs (swelling around the fetlock joint), arthritis and osteoarthritis, inflammation and diseases of the central nervous system; chemical therapeutic preparations in the form of vesicles for veterinary purposes for treating pain, inflammation, osteoarthritis, and dermatological conditions; chemical membranes for veterinary purposes for treating pain, inflammation, osteoarthritis, and dermatological conditions; chemical aggregates for veterinary purposes for treating pain, inflammation, osteoarthritis, and dermatological conditions; preparations of arachidonic acids for veterinary purposes; pharmaceuticals for the treatment of hoof fungal infections; creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solutions for the treatment of pain or inflammation; surfactants for use in the treatment of inflammatory diseases, diseases of the mouth, teeth, skin, hair and ear, eczema, psoriasis and pain; serum, namely, medicated serum for treatment of skin; medicated skin toners; medicated soap

Toiletries, namely, non-medicated toiletry preparations; non-medicated skin care preparations; face cleansers; cosmetic preparations for skin care; serum, namely, non-medicated skin serum; beauty balms; skin balms; skin toners; exfoliators, namely, cosmetic exfoliant creams and scrubs; cosmetic eye masks; face masks, namely, beauty mask for faces; non-medicated skin toners; cosmetic skin cream, oils, lotions and sprays; skin conditioners; moisturisers, namely, skin, face, body, and hand moisturizers; eye cream; eye gel; lip moisturisers; lip balm; hand cream; body lotions; body washes; cosmetic foot balms; body scrubs; skin care kits consisting primarily of cosmetics; toiletry kits consisting primarily of cosmetics; essential oils; fragrances; non-medicated soap; hair care preparations; dentifrices; cosmetics; dispersions and dry preparations of liposomal active substance carriers for cosmetic preparations

Lipids and surfactants being chemical preparations for use in industry and science; surfactants and lipids for use in personal care products; chemical products, namely, chemicals for in vitro or in vivo use in research and product development; chemical products, namely, chemicals for use in science and in research; ingredients for use in cosmetic preparations, namely, collagen and emollient; active chemical ingredients for use in the course of manufacture of pharmaceuticals for treating dermatological conditions and skincare products; active chemical ingredients for use in the course of manufacture of pharmaceuticals, namely, veterinary, dietetic, and dietary pharmaceuticals and dietary pharmaceuticals; diagnostic preparations and substances, all for scientific in vivo use; biochemical preparations of arachidonic acids for scientific purposes

Medical devices for topical use for the treatment of pain; molecular filtering devices for medical use; medical, veterinary and surgical apparatus, instruments and devices; inhalers; injection apparatus, instruments and devices with and without needles; apparatus, instruments and devices, namely, droppers, injection devices, and tubing for dispensing medical, surgical and veterinary preparations, dispersions, creams, powders, tablets and pills; instruments and devices for the administration of therapy and prophylaxis preparations and substances, namely, droppers, injection devices, and tubing; molecular filtering devices for veterinary use; veterinary devices for the treatment of laminitis and debilitating joint diseases, bog spavin and bone spavin, bowed tendons, capped joints, curb (inflammation of the rear cannon bone below the point of hock), laminitis, navicular disease, osselets, ringbone, sesamoiditis, shoe boil, sidebone, speedy cut (striking of the inner lower side of the knee with the opposite limb), splints; veterinary devices for the treatment of sprains, stocking up, stringhalt, thoroughpin (swelling of the digital flexor tendon sheath), and windpuffs (swelling around the fetlock joint), arthritis and osteoarthritis, inflammation and diseases of the central nervous system; veterinary instruments and devices for dispensing veterinary preparations, dispersions, creams, powders, tablets and pills; veterinary devices for the administration of pain relief, therapy and prophylaxis; parts and fittings for the aforesaid; Medical devices for topical use in the treatment of dermal conditions associated with all layers of the skin, superficial and deep; instruments and devices for the administration of skin disease and aging therapy and prophylaxis preparations and substances; structural parts and fittings for all of the aforesaid; face masks for use by healthcare providers; fashion masks being sanitary face masks for protection against viral infection; Medical apparatus, instruments and devices, namely, a medical device in which vesicles act in the nature of non-pharmaceutical nanostructures dispersed in a gel and which migrate through the skin and have a physical therapeutic effect; Medical apparatus, instruments and devices, namely, a medical device in which vesicles act as a drug delivery device dispersed in a gel and which migrate through the skin to deliver a pharmaceutical that has a therapeutic effect

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 31, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 31, 2022 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Apr 26, 2022 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 26, 2022 AITU
NOTICE OF ALLOWANCE CANCELLED
Mar 16, 2022 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Mar 16, 2022 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 15, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 15, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 15, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 15, 2021 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 18, 2021 GNFN
FINAL REFUSAL E-MAILED
Jul 18, 2021 GNFR
FINAL REFUSAL WRITTEN
Jul 18, 2021 CNFR
DATA MODIFICATION COMPLETED
Jun 30, 2021 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 29, 2021 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2021 CRFA
ASSIGNED TO LIE
Jun 25, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 28, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2020 NWOS
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 10, 2020 AMPX
ASSIGNED TO LIE
Aug 3, 2020 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 20, 2020 PARI
NEW APPLICATION ENTERED
Jul 18, 2020 NWAP